Background: Gemfibrozil is a member of fibrates (gemfibrozil, fenofibrate, ceprofibrate, and benzafibrate) which is employed for treatment of dyslipidemia particularly hypertriglyceridemiae through its action on peroxisome proliflator activated receptors (PPAR-α). Objective: The aim of this work was to study the site of action and pharmacololgical effects of different doses of gemfibrozil on some isolated smooth muscles preparations of experimental animals. Materials and Methods: The experiments were conducted on isolated jejunum of rabbits, isolated spiral tracheal and urinary bladder strips of guinea pigs. Results: I-On isolated rabbit jejunum, gemfibrozil produced a dose-dependent reduction on the amplitude of jejunal contractions. The inhibitory effect of gemfibrozil was not abolished after complete blockade of alpha and beta adrenergic receptors, while it was completely abolished after inhibition of nitric oxide synthase by N-methyl L-arginine. On the other hand the stimulatory effects of nicotine small dose, acetylcholine, calcium gluconate, histamine and serotonin were not abolished after administration of gemfibrozil. II-On isolated tracheal spiral strips of ginea pigs, gemfibrozil produced a dose-dependent relaxation on the basal tone and a dose-dependent reduction on the amplitude of acetylcholine-induced tracheal contractions of the tracheal strips. The inhibitory effect of gemfibrozil was completely abolished after inhibition of nitric oxide synthase by N-methyl L-arginine. Gemfibrozil completely abolished also serotonin-induced contraction, while it has no effect on histamine or calcium-induced tracheal contractions. III-On isolated urinary bladder strips of guinea pigs, gemfibrozil produced a dose-dependent reduction on the amplitude of urinary bladder contractions. The inhibitory effect of gemfibrozil was not abolished after complete blockade of beta adrenergic receptors, while it was completely abolished after inhibition of nitric oxide synthase by N-methyl L-arginine. On the other hand the stimulatory effects of acetylcholine and serotonin were not abolished after administration of gemfibrozil. Conclusion: Gemfibrozil (antidyslipidemic, PPAR-α agonist) reduced jejunal and urinary bladder contractions and has a relaxant effect on tracheal basal tone. So it has a beneficial effect in obstructive airway diseases and cases of urgency and frequency of micturation and urinary incontinence. However, it may be used cauciously in cases of ,GIT disturbances as constipation and prostatic hypertrophy.
INTRODUCTION
Gemfibrozil (member of fibrates) is PPAR-α agonist which improves lipid profiles particulary very low density lipoprotein and high density lipoprotein in patients with dyslipidemia
Peroxisome proliferator activated receptors (PPARs) are steroid receptors that exhibit broad tissue expression pattern 3, 4 . They regulate the expression of a wide array of genes that are involved in fatty acids uptake and oxidation, inflammations and vascular function 5 . The intensive studies of PPARs have revealed their importance in both normal physiology and pathology of various tissues 6 .
Phelps and Peuler reported that fibrates has direct smooth muscle relaxant effect through inhibition of duodenal and urinary bladder contractions

7
. This is in agreement with the study of Nijkamp et al. reported that gemfibrozil has a relaxant effect on the tracheal basal tone Generally, the mechanism of the inhibitory effect of gemfibrozil on different smooth muscles is still unclear. So this work aimes to study the effect of gemfibrozil on some isolated smooth muscles of jejunum, trachea and urinary bladder, and its possible mechanism of action 8 .
MATERIAL AND METHODS
Gemfibrozil was supplied in the form of tablets which were film coated Each tablet Pharmacological Effects of Gemfibrozil… 2 contained 600mg gemfibrozil which was dissolved in 60ml distilled water
9
. It was tested on the following strips:
I-Experiments on isolated rabbit jejunum
10
:
The effect of test drug on jejunal contractions was obtained using gradually increasing doses of gemfibrozil (25-800 μg/ml). Effect of gemfibrozil (100 μg/ml) on the amplitude of jejunal contractions was studied before and after complete blockade of either α-adrenoceptors or β-adrenoceptors. Also, effects of gemfibrozil (100 μg/ml) on the stimulant effect of nicotine (1 μg/ml), acetylcholine (0.05 μg/ml), calcium gluconate (300 μg/ml), histamine (0.05 μg/ml) and serotonin (0.1 μg/ml) on the amplitude of jejunal contractions was studied. Further the inhibitory effect of gemfibrozil (100 μg/ml) on the jejunal contractions were studied before and after inhibition of nitric oxide synthase by N-methyl L-arginine (100 μg/ml): II-Experiments on isolated tracheal spiral strips of guinea pigs 11 : The effect of gemfibrozil (40-1280 ug/ml) on the tracheal basal tone against acetylcholine (3 μg/ml) induced contractions was tested. Effect of gemfibrozil (320 µg/ml) on either serotonergic receptors, histaminic receptors or calcium channels were conducted. The inhibitory effects of gemfibrozil (320 ug/ml) on acetylcholine (3 µg/ml) induced contractions of isolated tracheal spiral strips of guinea pigs were studied before and after inhibition of nitric oxide synthase by N-methyl L-arginine (100 μg/ml): III-Experiments on isolated urinary bladder strips of guinea pigs 12 : The effect of gemfibrozil (40-1280 ug/ml) on the amplitude of urinary bladder contractions was tested.The Effect of gemfibrozil (320 μg/ml) on the amplitude of urinary bladder contractions was recorded before and after blocking β-adrenergic receptors. The effect of gemfibrozil (320 μg/ml) on muscarinic receptors and serotonergic receptors was studied. Also, the inhibitory effect of gemfibrozil (320 μg/ml) on the amplitude of urinary bladder contractions was studied before and after inhibition of nitric oxide synthase by N-methyl L-arginine (100 μg/ml).
Statistical analysis: Statistical analysis was done using SPSS 14.0 for windows. Significant value was considered when p value <0.05. Student t-test of significant was used 13 . RESULTS I-On isolated rabbit jejunum:
Effect of gemfibrozil (25-800 μg/ml) on the amplitude of jejunal contractions (cm): Gemfibrozil (25-800μg/ml) produced a dose-dependent reduction on the amplitude of jejunal contractions (Fig. 1) . The mean percent reduction±SEM ranged from 13.91±1.97 to 81.97±2.52 was found to be statistically significant while the mean percent reduction±SEM (3.63±1.50) was found to be statistically insignificant (Table 1) . Gemfibrozil (100 μg/ml) produced reduction in the amplitude of jejunal contractions after complete blockade of alpha-and betaadrenergic receptors (Fig. 2, 3 ). The stimulant effect of either nicotine small dose (1 μg/ml), acetylcholine (0.05 μg/ml), calcium gluconate (300 μg/ml), histamine (0.05 μg/ml) or serotonin (0.1 μg/ml), on the amplitude of jejunal contractions was not abolished after administration of gemfibrozil (100 μg/m) (Fig. 4, 5, 6, 7, 8) . The inhibitory effect of gemfibrozil (100 μg/ml) on the amplitude of jejunal contractions was completely abolished after inhibition of nitric oxide synthase by N-methyl L-arginine (100 μg/ml) (Fig. 9) . II-On isolated tracheal spiral strips of guinea pigs: -Effect of gemfibrozil on the basal tone of tracheal spiral strips of guinea pigs:
Gemfibrozil (40-1280 μg/ml) produced relaxant effect on the basal tone of tracheal spiral strips of guinea pigs in a dose-dependent manner (Fig. 10) . The mean relaxant effect±SEM ranged from 0.06±0.02 to 0.16±0.01 was found to be statistically significant, while the mean relaxant effect ± SEM (0.03 ± 0.02) was found to be statistically insignificant (Table 2 ). On acetylcholine (3 μg/ml) induced contractions (cm) , gemfibrozil at small doses (40 and 80 μg/ml) did not produce any effect, while at doses (160-1280 μg/ml) produced a dose-dependent reduction on the amplitude of acetylcholine induced tracheal contractions (Fig. 11) . The mean percent reductions±SEM ranged from 15.54±2.53 to 55.44±3.61 which were found to be statistically significant (Table 3) . Also ,Gemfibrozil (320 μg/ml) completely abolished the serotonin (5 μg/ml) induced contractions while it has no effect on histamine (3 μg/ml) or calcium gluconate (50 μg/ml) induced contractions of isolated tracheal spiral strips of guinea pigs (Fig. 12,13,14) . The inhibitory effect of gemfibrozil (320 μg/ml) on acetylcholine (3 μg/ml) induced contraction of isolated tracheal spiral strips of guinea pigs which was completely abolished after inhibition of nitric oxide synthase by N-methyl L-arginine (Fig. 15) . III-On isolated urinary bladder strips of guinea pigs: -Effect of Gemfibrozil (40-1280 μg/ml) on amplitude of urinary bladder contractions (cm): Gemfibrozil (40-1280 μg/ml) produced a dosedependent reduction on the amplitude of urinary bladder contractions (Fig. 16 ). The mean percent reductions±SEM ranged from 7.29±2.44 to 98.54±1.04 which were statistically significant (Table 4) . Gemfibrozil (320 μg/ml) produced reduction on the amplitude of urinary bladder contractions after complete blockade of beta adrenergic receptors. The stimulant effect of either acetylcholine (3 µg/ml) or serotonin (0.1 µg/ml) on the amplitude of urinary bladder contractions was not abolished after administration of gemfibrozil (320 µg/ml). (Fig. 17, 18, 19) The inhibitory effect of gemfibrozil (320μg/ml) on the amplitude of urinary bladder contractions was completely abolished after inhibition of nitric oxide synthase by N-methyl L-arginine (100 μg/ml) (Fig. 20) .
DISCUSSION
In this work the experiments on isolated rabbit jejunum revealed that gemfibrozil (25-800 µg/ml) produced reduction on the amplitude of jejunal contractions in a dose-dependent manner. This result was in agreement with that of Peuler and Phelps who reported that gemfibrozil immediately inhibited the contraction of duodenum of rabbit
14
. In addition, Phelps and Peuler mentioned also that the amplitude of duodenal spontaneous contractions was inhibited by gemfibrozil
7
. The mechanism of this inhibitory effect which was studied in the present work suggested that it was through stimulation of NO synthase. This mechanism may explain what reported by Phelps and Peuler who concluded that gemfibrozil has direct smooth muscle relaxant properties
15
. In addition, Phelps and Peuler reported that gemfibrozil can directly inhibit the force of spontaneously occurring phasic rhythmic smooth muscle contractions and its primary site of action is the smooth muscle itself, either by inhibiting its responsiveness to endogenous contractile substances and/or its inherent ability to contract spontaneously on its own 7 . The effect of gemfibrozil on isolated jejunum of rabbits represented reasonable explanation for common gastrointestinal side effects manifested by gemfibrozil treated patients; abdominal pain, dyspepsia, nausea, vomiting and constipation 16, 2 . In the present work the experiments on isolated tracheal spiral strips of guinea pigs showed that gemfibrozil (80-1280 µg/ml) revealed significant relaxation on the basal tone and also, gemfibrozil (160-1280 µg/ml) revealed significant reduction on the amplitude of acetylcholine induced contractions. The inhibitory effect of gemfibrozil (320 μg/ml) on acetylcholine induced contractions was completely abolished after inhibition of NOS and completely inhibited serotonin-induced contractions.
The relaxant effect on the basal tone by gemfibrozil was supported by study of Becker et al. which had revealed that perfusion through the lumen of guinea pig tracheal tubes in vitro with NOS inhibitors resulted in a significant increase in basal tone, suggesting a role for NO in the maintenance of basal tone
17
. The inhibitory effect of gemfibrozil on acetylcholine induced contractions which was completely abolished after inhibition of NOS in this work is in agreement with the study of Becker et al. who reported that fenofibrate (PPAR-α agonist) decreased mice airway reactivity to methacholine and mice treated with fenofibrate and administered L-nitro arginine methyl ester
. L-NAME; (NOS inhibitor) exhibited similar reactivity to methacholine as in non treated mice suggesting that NO mediate fenofibrate induced decrease in airway reactivity. The same authors measured the level of eNOS in the lung from mice treated with fenofibrate and found that its level remains unchanged, but its activation through phosphorelation severely increases
17)
The nitric oxide in the airway is released from epithelial cells, nerve, and inflammatory cells and modulate the responsiveness of airway smooth muscle to acetylcholine (18, 19) . Finally, all the previous data suggesting that it has a benefit Gemfibrozil (antidyslipidemic, PPAR-α agonist) reduced jejunal and urinary bladder contractions, and has a relaxant effect on tracheal basal tone. This suggested that Gemfibrozil has a beneficial effect in obstructive airway diseases and cases of urgency and frequency of micturation and urinary incontinence. However, it may be used cauciously in cases of heart failure, GIT disturbances as constipation and prostatic hypertrophy. 
